4

OWNERSHIP DOCUMENT

Company: Inhibitor Therapeutics, Inc.
Filed: July 20, 2020
Period of Report: July 15, 2020
Accession Number: 0001104659-20-084975

View Document ↗ View on SEC.gov ↗